Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study

Trial Profile

Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 13 Jul 2017

At a glance

  • Drugs Glimepiride (Primary) ; Insulin glargine (Primary) ; Liraglutide (Primary) ; Sitagliptin (Primary) ; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Registrational; Therapeutic Use
  • Acronyms GRADE
  • Most Recent Events

    • 07 Jul 2017 Status changed from recruiting to active, no longer recruiting.
    • 10 Jun 2017 Biomarkers information updated
    • 29 Apr 2015 Last checked against Oregon Health and Science University Institutional Review Board.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top